Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$257M |
| 2 |
JPMorgan Chase
JPM
|
+$211M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
Home Depot
HD
|
+$183M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$182M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
Meta Platforms (Facebook)
META
|
+$132M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$129M |
| 4 |
NVIDIA
NVDA
|
+$127M |
| 5 |
Merck
MRK
|
+$108M |
Sector Composition
| 1 | Healthcare | 14.98% |
| 2 | Technology | 13.18% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Relmada Therapeutics
RLMD
$52.8M
| $1.94M | ﹤0.01% |
43,328
+4,905
| +13% | +$220K |
|
2002
HealthEquity
HQY
$7.97B
| $1.94M | ﹤0.01% |
33,033
-79,683
| -71% | -$4.67M |
|
2003
Vital Energy
VTLE
$635M
| $1.94M | ﹤0.01% |
139,684
+69,693
| +100% | +$966K |
|
2004
Opko Health
OPK
$1.11B
| $1.93M | ﹤0.01% |
564,873
-3,006,526
| -84% | -$10.3M |
|
2005
Scholar Rock
SRRK
$3.04B
| $1.92M | ﹤0.01% |
+105,489
| New | +$1.92M |
|
2006
iShares MSCI Hong Kong ETF
EWH
$737M
| $1.92M | ﹤0.01% |
+89,688
| New | +$1.92M |
|
|
TLND
2007
DELISTED
Talend S.A. American Depositary Shares
TLND
| $1.91M | ﹤0.01% |
+55,180
| New | +$1.91M |
|
2008
Braskem
BAK
$1.33B
| $1.91M | ﹤0.01% |
+220,717
| New | +$1.91M |
|
|
PRVL
2009
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $1.9M | ﹤0.01% |
127,811
+31,124
| +32% | +$464K |
|
2010
CuriosityStream
CURI
$281M
| $1.9M | ﹤0.01% |
189,000
-61,000
| -24% | -$613K |
|
2011
WisdomTree India Earnings Fund ETF
EPI
$2.93B
| $1.9M | ﹤0.01% |
94,782
-75,735
| -44% | -$1.52M |
|
2012
Regis Corp
RGS
$70.8M
| $1.9M | ﹤0.01% |
11,588
+11,035
| +1,995% | +$1.81M |
|
2013
PolyPid
PYPD
$55.2M
| $1.89M | ﹤0.01% |
+3,500
| New | +$1.89M |
|
|
KAMN
2014
DELISTED
Kaman Corp
KAMN
| $1.89M | ﹤0.01% |
+45,493
| New | +$1.89M |
|
2015
Bio-Techne
TECH
$7.97B
| $1.89M | ﹤0.01% |
28,644
-5,860
| -17% | -$387K |
|
2016
Smith & Wesson
SWBI
$415M
| $1.89M | ﹤0.01% |
114,102
-522,823
| -82% | -$8.65M |
|
2017
Boston Omaha
BOC
$425M
| $1.88M | ﹤0.01% |
117,595
+97,878
| +496% | +$1.57M |
|
2018
Alamos Gold
AGI
$13.9B
| $1.88M | ﹤0.01% |
200,274
-985,440
| -83% | -$9.25M |
|
|
UBA
2019
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.87M | ﹤0.01% |
157,761
-47,208
| -23% | -$561K |
|
2020
HCA Healthcare
HCA
$94.8B
| $1.87M | ﹤0.01% |
19,253
-195,024
| -91% | -$18.9M |
|
2021
CGI
GIB
$20.8B
| $1.87M | ﹤0.01% |
29,635
-247,243
| -89% | -$15.6M |
|
2022
iShares Silver Trust
SLV
$20.7B
| $1.86M | ﹤0.01% |
+109,598
| New | +$1.86M |
|
|
HMHC
2023
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.86M | ﹤0.01% |
1,028,243
+324,472
| +46% | +$587K |
|
2024
CAE Inc
CAE
$8.47B
| $1.86M | ﹤0.01% |
114,846
+68,173
| +146% | +$1.1M |
|
|
HES
2025
DELISTED
Hess
HES
| $1.86M | ﹤0.01% |
35,870
-360,023
| -91% | -$18.6M |
|